AiPEX: AiPEX™ is a formal AiCure-CRO partnership, designed to provide higher quality data and robust insights for faster and smaller clinical trials.
AiCure ePRO: Empower Patients, Sites And Sponsors For Better Insights To Safety And Efficacy Results
AiCure Dosing Support, Adherence & Insights: Powerful Safety And Efficacy Insights Captured With Dosing And Medication Adherence Software
AiCure Patient Connect: AiCure Patient Connect™ enables sites to connect with patients via video chat in a HIPAA and GDPR compliant manner.
COVID-19 New Trial Planning: Navigate Uncertainty: Plan Upcoming Trials With Remote And Mobile Enablement
COVID-19 Trial Continuity: Remote Patient Assessment And Medication Adherence For Patient Safety And Data Integrity
White Papers & Publications
Real-word evidence & Cost effectiveness
Clinical Trial Methodology
Rich Christie, M.D., Ph.D., AiCure – PharmaVOICE Interview
AiCure offers the only platform that can accurately confirm our trial participants are taking the right medication at the right dosage, while also capturing valuable behavioral and endpoint data – helping us to advance our clinical trial for a potential treatment of diabetic neuropathic pain.
We are delighted to lead an investment in AiCure – a true growth leader that is able to help the pharmaceutical industry develop better medications.
AiCure is at the forefront of therapeutic intelligence, assisted by an extensive clinical evidence base, and rooted in an enviable intellectual property portfolio.
Collaborating with AiCure is a unique opportunity to bring deeper and more novel insights to clinical research without participants ever having to leave the comfort of home.
The AiCure platform aligns with our unique product development model that harnesses behavioral insights to unlock real world experiences.